InvestorsHub Logo
Followers 91
Posts 4810
Boards Moderated 0
Alias Born 05/11/2006

Re: gi197845 post# 3005

Monday, 04/05/2021 3:01:20 PM

Monday, April 05, 2021 3:01:20 PM

Post# of 3196
Thank you. I used to love biopharmas, but the FDA's new hard guy position on this and other biopharmas has made them not worth the risk of owning, in my opinion. It's too bad, because it will make raising capital more expensive for the whole industry, especially fledgling drug companies, and will hinder the development of drugs that could have massive benefit for society. For example, I would love to put some money into ALRN, as they have the potential to develop a drug that's similar or superior in efficacy to that for which GTHX just got approval, but I wouldn't touch it now because of the risk of their running afoul of the FDA in the approval process.

I think you're going to be O.K. here in the long run, but I sold this and put the money into WKHS because I don't have the time to let this money sit here dead for an indeterminate period of time when WKHS has a product that can transform the face of end-mile transportation, and they don't have to wait for FDA approval to move forward.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ACAD News